Vontobel Asset Management Inc. Has $19,085,000 Position in Henry Schein Inc. (HSIC)
Vontobel Asset Management Inc. boosted its position in shares of Henry Schein Inc. (NASDAQ:HSIC) by 43.7% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 117,093 shares of the company’s stock after buying an additional 35,600 shares during the period. Vontobel Asset Management Inc. owned 0.14% of Henry Schein worth $19,085,000 as of its most recent SEC filing.
Several other hedge funds have also recently bought and sold shares of HSIC. AMP Capital Investors Ltd raised its stake in Henry Schein by 1.7% in the first quarter. AMP Capital Investors Ltd now owns 23,958 shares of the company’s stock worth $4,141,000 after buying an additional 400 shares in the last quarter. A.R.T. Advisors LLC purchased a new stake in Henry Schein during the first quarter worth about $1,792,000. LPL Financial LLC raised its stake in Henry Schein by 22.1% in the first quarter. LPL Financial LLC now owns 27,724 shares of the company’s stock worth $4,702,000 after buying an additional 5,012 shares in the last quarter. Arizona State Retirement System raised its stake in Henry Schein by 1.1% in the first quarter. Arizona State Retirement System now owns 62,500 shares of the company’s stock worth $10,789,000 after buying an additional 700 shares in the last quarter. Finally, Exxonmobil Investment Management Inc. TX raised its stake in Henry Schein by 6.5% in the second quarter. Exxonmobil Investment Management Inc. TX now owns 21,243 shares of the company’s stock worth $3,756,000 after buying an additional 1,292 shares in the last quarter. Institutional investors own 92.91% of the company’s stock.
Shares of Henry Schein Inc. (NASDAQ:HSIC) traded down 5.36% during trading on Monday, hitting $148.55. 2,876,503 shares of the stock traded hands. The firm’s 50-day moving average price is $155.87 and its 200-day moving average price is $167.10. The company has a market cap of $11.96 billion, a price-to-earnings ratio of 24.67 and a beta of 1.09. Henry Schein Inc. has a 52 week low of $142.64 and a 52 week high of $183.00.
Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings results on Wednesday, November 2nd. The company reported $1.68 EPS for the quarter, topping analysts’ consensus estimates of $1.65 by $0.03. Henry Schein had a return on equity of 18.15% and a net margin of 4.40%. The company earned $2.87 billion during the quarter, compared to analyst estimates of $2.88 billion. During the same period in the previous year, the company earned $1.55 earnings per share. The company’s quarterly revenue was up 6.7% compared to the same quarter last year. On average, equities research analysts anticipate that Henry Schein Inc. will post $6.58 earnings per share for the current year.
A number of research firms have recently weighed in on HSIC. Zacks Investment Research downgraded shares of Henry Schein from a “hold” rating to a “sell” rating in a research report on Monday, August 8th. Bank of America Corp. began coverage on shares of Henry Schein in a research report on Monday, September 12th. They set a “buy” rating and a $185.00 price target for the company. Robert W. Baird reissued an “outperform” rating and set a $176.00 price target (up previously from $175.00) on shares of Henry Schein in a research report on Tuesday, October 4th. Goldman Sachs Group Inc. raised shares of Henry Schein from a “neutral” rating to a “buy” rating and set a $185.00 price target for the company in a research report on Tuesday, October 11th. Finally, Leerink Swann reissued a “hold” rating on shares of Henry Schein in a research report on Thursday, November 3rd. Seven investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. The company has a consensus rating of “Hold” and an average price target of $172.83.
In other news, EVP Mark E. Mlotek sold 2,417 shares of the company’s stock in a transaction that occurred on Thursday, November 3rd. The stock was sold at an average price of $155.19, for a total transaction of $375,094.23. Following the completion of the transaction, the executive vice president now directly owns 40,456 shares in the company, valued at $6,278,366.64. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Paul Brons sold 3,381 shares of the company’s stock in a transaction that occurred on Monday, August 29th. The stock was sold at an average price of $164.03, for a total value of $554,585.43. Following the transaction, the director now owns 13,715 shares of the company’s stock, valued at $2,249,671.45. The disclosure for this sale can be found here. Insiders own 1.27% of the company’s stock.
Henry Schein Company Profile
Henry Schein, Inc is a provider of health care products and services to office-based dental, animal health and medical practitioners. The Company’s segments include healthcare distribution, and technology and value-added services. The healthcare distribution segment aggregates its global dental, animal health and medical operating segments.
Receive News & Stock Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related stocks with our FREE daily email newsletter.